Darbitop 25mcg Injection
Prescription Required
Product introduction
Darbitop 25mcg Injection is used in the treatment of anemia that may have occurred due to chronic kidney disease or chemotherapy. It works by stimulating the bone marrow to produce more red blood cells.
Darbitop 25mcg Injection is used to treat anemia (deficiency of red blood cells in blood)
Darbitop 25mcg Injection is used to treat anemia (deficiency of red blood cells in blood)
Uses of Darbitop Injection
Benefits of Darbitop Injection
In Treatment of Anemia due to chronic kidney disease
Anemia is a condition where your body does not have enough red blood cells to carry oxygen around your body. Chronic kidney disease (CKD) refers to the loss of normal kidney function over a long span of time. CKD progresses gradually over a few years but may become permanent if left untreated. CKD can lead to anemia. Darbitop 25mcg Injection can boost your levels of red blood cells and reduce the symptoms of anemia such as tiredness and weakness. Taking this injection improves the quality of life.
In Treatment of Anemia due to cancer chemotherapy
Low red blood cell count is termed as anemia. Cancer treatment with chemotherapy often causes many side effects, one of the major ones being anemia. Darbitop 25mcg Injection stimulates the production of red blood cells in bone marrow and regulates the haemoglobin in the blood. This treats anemia in cancer patients receiving chemotherapy.
Side effects of Darbitop Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Darbitop
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Darbitop Injection
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Darbitop 25mcg Injection. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Darbitop 25mcg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Darbitop 25mcg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
SAFE
Darbitop 25mcg Injection does not usually affect your ability to drive.
Kidney
SAFE IF PRESCRIBED
Darbitop 25mcg Injection is safe to use in patients with kidney disease. No dose adjustment of Darbitop 25mcg Injection is recommended.
Liver
CAUTION
Darbitop 25mcg Injection should be used with caution in patients with liver disease. Dose adjustment of Darbitop 25mcg Injection may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Darbitop 25mcg Injection
₹2050.0/Injection
Dargen 25 Injection
Lupin Ltd
₹1523/injection
26% cheaper
Actorise 25 Injection
Cipla Ltd
₹1650/injection
20% cheaper
Cresp 25 Injection
Dr Reddy's Laboratories Ltd
₹1749/injection
15% cheaper
Darcept 25 Injection
LG Lifesciences
₹1800/injection
12% cheaper
Darbatitor 25mcg Injection
Torrent Pharmaceuticals Ltd
₹1585/injection
23% cheaper
Quick tips
- Darbitop 25mcg Injection helps in the treatment of anemia that may have occurred due to chronic kidney disease or cancer chemotherapy.
- It is given as a single injection under your skin, additionally, it can be given intravenously.
- Your doctor may get your blood tests done regularly to monitor the levels of hemoglobin, blood cells, in your blood.
- Stop taking Darbitop 25mcg Injection and inform your doctor if you develop shortness of breath or skin rash.
Fact Box
Chemical Class
Amino Acids, Peptides Analogues
Habit Forming
No
Therapeutic Class
BLOOD RELATED
Action Class
Erythropoiesis-stimulating agent (ESA)
Patient concerns
FAQs
How long does it take for Darbitop 25mcg Injection to start working?
You will be able to notice an increase in the count of red blood cells (hemoglobin levels) in 2-6 weeks of starting Darbitop 25mcg Injection. If you have any other concerns, consult your doctor.
Is Darbitop 25mcg Injection safe to use?
Darbitop 25mcg Injection is a medicine that needs to be used with utmost care because it can lead to serious side effects and even death of the patient. It is important that you seek treatment from a doctor who is experienced in providing Darbitop 25mcg Injection therapy. Follow all the directions strictly.
Other than PRCA, can there be other reasons for not responding to Darbitop 25mcg Injection?
You may not respond to Darbitop 25mcg Injection if you have deficiencies of iron, folic acid or vitamin B12. It is important that you take measures to correct these deficiencies. Other reasons behind not responding to the treatment could be bleeding, infections, inflammation and bone marrow fibrosis. Therefore, consult our doctor regarding the same.
Can Darbitop 25mcg Injection be used in children?
Yes, Darbitop 25mcg Injection is used to treat anemia due to chronic kidney disease in children who are above 1 year of age. The effectiveness of Darbitop 25mcg Injection and side effects seen in children are similar to adults. However, consult your doctor if you are not sure.
Can Darbitop 25mcg Injection affect blood pressure?
Yes, Darbitop 25mcg Injection can affect blood pressure. During initial therapy with Darbitop 25mcg Injection, blood pressure should be monitored and those who have high blood pressure should take appropriate measures to control blood pressure. Your doctor may stop Darbitop 25mcg Injection if the blood pressure remains uncontrolled.
Who should not take Darbitop 25mcg Injection?
Individuals who have cancer but have not been prescribed Darbitop 25mcg Injection by the doctor should not take it. Additionally, patients with uncontrolled hypertension (high blood pressure), patients with a history of anemia called pure red cell aplasia (PRCA) that starts after treatment with Darbitop 25mcg Injection or other erythropoietin medicines, and patients with a history of serious allergic reaction to this medicine should not take this medicine.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Kaushansky K, Kipps TJ. Hematopoietic Agents: Growth Factors, Minerals, and Vitamins. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1071-72.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 358-59.
- Darbepoetin alfa. Milton Road, Cambridge: Amgen Ltd.; 2001 [revised Sep. 2017]. [Accessed 23 Jan. 2019] (online) Available from:
- Darbepoetin alfa. Thousand Oaks, CA: Amgen Inc.; 2001. [Accessed 07 Apr. 2019] (online) Available from:
- CiplaMed. Darbepoetin Alfa [Product Information]. [Last Reviewed: June 2019]. [Accessed 17 Jun. 2023] (online) Available from:
- Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006. Darbepoetin. [Accessed 17 Jun. 2023] (online) Available from:
- Darbepoetin alfa [Prescribing Information]. Thousand Oaks, California: Amgen Inc.; 2019. [Accessed 17 Jun. 2023] (online) Available from:
- Aranesp Injection (Darbepoetin alfa) [Product Information]. [Accessed 17 Jun. 2023] (online) Available from:
Marketer details
Name: Alniche Life Sciences Pvt Ltd
Address: Alniche Life Sciences Pvt. Ltd., S-14, 2nd Floor, Janta Market Rajouri Garden, New Delhi – 110 027
Country of origin: India
Lab tests offered by us
Related/Popular tests
112 people viewed this recentlyMRP
₹2050
Inclusive of all taxes
1.0 Injection in 1 vial
SOLD OUT